SFM
OMGA

Sphera Funds Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Sphera Funds Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-352,948
Closed -$4M – 98
2021
Q4 		$4M Sell
352,948
-175,000
-33% -$3.33M 0.44% 62
2021
Q3 		$9.95M Buy
+527,948
New +$10.1M 0.84% 41

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Sphera Funds Management's OMGA Position: Q1 2022 in Review

Sphera Funds Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2022, closing a stake of 352,948 shares — an estimated $4M sold.

Sphera Funds Management first reported a position in OMGA in Q3 2021 and held it in 2 quarters. The position peaked at $9.95M in Q3 2021. 52 funds tracked by Wall St. Rank hold OMGA as of Q1 2022.

  • Sphera Funds Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Sphera Funds Management sold 352,948 Omega Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $4M.
  • Sphera Funds Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Sphera Funds Management's Omega Therapeutics, Inc. Common Stock position peaked at $9.95M in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Sphera Funds Management's 13F filing for Q1 2022, filed 16 May 2022.